Sanofi Reports Uninspiring Q4 Sales Amid Skepticism On Dupixent’s COPD Potential

Revenues Fall Short Of Consensus

 
• By Ayisha Sharma
Woman with one thumb up and one thumb down against pink background, represents mixed views
The Mixed Results For Sanofi Left Analysts Lukewarm • Source: Shutterstock

More from Earnings

More from Business